Product
3B-EXOME
Whole exome sequencing-based
genetic testing service
Whole exome sequencing,
the most efficient genetic testing
3B-EXOME detects most of the rare genetic diseases by covering the exome region. You can consider 3B-EXOME primarily when it is difficult to determine the cause of the patient's condition.
Test Specification
illumina NovaSeq X
~100X
~100X
150bp paired-end
≥ 98%
SNV, INDEL, CNV
* For the mitochondrial genome variants, the level of heteroplasmy that can be reported is ≥10%
See cases diagnosed with
3B-EXOME
You can consider 3B-EXOME in the following circumstances
To conduct preliminary genetic testing
The ACMG recommends children with developmental, cognitive, and intellectual disabilities take a WES-based genetic test as a first-line test.
Showing non-specific symptoms
When the doctor suspects a genetic disease, but the disease cannot only be diagnosed with the patient's phenotypes, the patient/doctor can consider a WES.
Undiagnosed after multiple tests
Even after numerous panel tests, a WES test should be considered if disease-causing variants are still not detected.
One-stop test
Instead of multiple single/panel tests, the patient and doctor should consider a test covering all genes.
FAQs
- Is it possible to check if the patient's family members also have the variants found in the patient?
- What does “reanalysis” mean?
- How is 3B-EXOME different from panel testing?